Clinical Trials Browser

Phase 2 × Lymphoproliferative Disorders × arginine butyrate × Clear all

NCT00992732 2011-08-01

Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders

Phase 2 Terminated

Lymphoproliferative Disorders